Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell, Marginal Zone × ixabepilone × Clear all

NCT00052572 2013-06-24

Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders

Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell